GLP-1 drugs: what Florida Medicaid paid

Q: Does a paid prescription mean Florida Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Florida Medicaid shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Florida Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Florida Medicaid’s payment record shows

In 2026Q1, the product Florida Medicaid paid for most often was Ozempic®, at 16,877 prescriptions¹⁹ of the 25,480 to 25,642^{1,7,13,19,25,37,43} across all 8 products, or 66 percent of the published count.

Florida Medicaid itself reimbursed at least $25,666,791 for these products in the quarter, about $1,008 per prescription. Pharmacies were paid $25,827,421 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,286.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Florida Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Florida Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Florida Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Florida Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 235¹	<1%	$245,088	$245,088	$1,043
tirzepatideMounjaro®	Both7,563 managed care, 134 direct	at least 7,697⁷	30%	$8,103,300	$8,201,909	$1,053
semaglutideWegovy®	Managed care	at least 406¹³	2%	$522,063	$522,823	$1,286
semaglutideOzempic®	Both16,618 managed care, 259 direct	at least 16,877¹⁹	66%	$16,609,770	$16,668,217	$984
semaglutideRybelsus®	Both	at least 163²⁵	<1%	$160,587	$163,400	$985
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	at least 11³⁷	<1%	$8,628	$8,628	$784
liraglutideliraglutide (generic)	Managed care	at least 73⁴³	<1%	$17,357	$17,357	$238

Florida Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 7.5 prescriptions per thousand people enrolled in Florida Medicaid, on an average of 3,414,095 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 19 of the 168 product-quarters it holds a row for here, which is 11 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Florida Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Florida Medicaid paid for each product, quarter by quarter

Prescriptions Florida Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld2 of 2 product codes withheld	at least 11 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$10,838 paid	at least 17 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$17,595 paid	at least 48 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$50,050 paid	at least 115 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$119,369 paid	at least 235 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$245,088 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 66 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$60,219 paid	at least 383 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$348,290 paid	at least 920 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$871,187 paid	at least 1,673 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$1,594,977 paid	at least 2,025 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$1,944,012 paid	at least 2,288 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$2,193,870 paid	at least 2,706 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$2,693,302 paid	at least 2,346 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$2,365,065 paid	at least 2,451 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$2,463,261 paid	at least 2,508 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$2,519,415 paid	at least 2,852 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$2,876,315 paid	at least 3,591 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$3,647,789 paid	at least 3,704 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$3,777,251 paid	at least 5,139 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$5,234,753 paid	at least 7,697 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$8,103,300 paid
semaglutideWegovy®range 151 to 285	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	at least 36 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$46,311 paid	at least 103 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁶At least$131,133 paid	at least 46 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$58,656 paid	at least 11 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁶At least$13,949 paid	at least 13 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld¹⁵At least$16,206 paid	at least 15 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$20,716 paid	at least 108 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$137,540 paid	151 paid prescriptions in the quarter (2024Q4)¹⁵Count$192,348 paid	202 paid prescriptions in the quarter (2025Q1)¹⁴Count$257,625 paid	254 paid prescriptions in the quarter (2025Q2)¹⁴Count$325,955 paid	234 paid prescriptions in the quarter (2025Q3)¹⁴Count$299,589 paid	285 paid prescriptions in the quarter (2025Q4)¹⁴Count$364,432 paid	at least 406 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$522,063 paid
semaglutideOzempic®	at least 740 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$578,519 paid	at least 854 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$686,934 paid	at least 933 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$736,841 paid	1,721 paid prescriptions in the quarter (2021Q4)²⁴Count$1,372,035 paid	at least 1,948 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$1,644,835 paid	at least 1,860 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,579,784 paid	at least 2,267 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,930,167 paid	at least 2,167 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$1,817,825 paid	at least 3,890 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$3,383,712 paid	at least 7,711 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$6,734,307 paid	at least 10,657 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$9,332,171 paid	at least 11,333 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$10,000,921 paid	at least 15,835 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$14,526,427 paid	at least 19,170 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$17,624,554 paid	at least 21,687 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$19,981,812 paid	at least 22,529 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$20,782,512 paid	at least 24,257 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$23,023,848 paid	at least 24,915 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$23,745,145 paid	at least 20,521 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$19,623,998 paid	at least 18,818 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$17,978,574 paid	at least 16,877 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$16,609,770 paid
semaglutideRybelsus®	at least 64 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$51,957 paid	at least 119 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$99,597 paid	at least 164 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$148,121 paid	at least 356 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$293,298 paid	at least 385 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$324,897 paid	at least 285 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$242,527 paid	at least 287 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$244,652 paid	at least 344 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$293,841 paid	at least 449 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$390,616 paid	at least 555 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$486,167 paid	at least 499 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$443,961 paid	at least 468 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$411,511 paid	at least 456 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$416,355 paid	at least 327 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$296,728 paid	at least 266 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$238,433 paid	at least 270 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$245,599 paid	at least 264 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$248,112 paid	at least 267 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$252,788 paid	at least 217 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$205,727 paid	at least 175 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$170,678 paid	at least 163 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$160,587 paid
liraglutideSaxenda®range 12 to 43	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	17 paid prescriptions in the quarter (2021Q2)³⁶Count$22,215 paid	28 paid prescriptions in the quarter (2021Q3)³⁶Count$36,308 paid	31 paid prescriptions in the quarter (2021Q4)³⁶Count$40,421 paid	25 paid prescriptions in the quarter (2022Q1)³⁵Count$31,497 paid	19 paid prescriptions in the quarter (2022Q2)³⁵Count$22,993 paid	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	16 paid prescriptions in the quarter (2022Q4)³⁵Count$18,937 paid	42 paid prescriptions in the quarter (2023Q1)³⁴Count$47,056 paid	43 paid prescriptions in the quarter (2023Q2)³⁴Count$52,602 paid	31 paid prescriptions in the quarter (2023Q3)³⁴Count$37,586 paid	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	12 paid prescriptions in the quarter (2024Q2)³³Count$8,738 paid	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 34 to 502	at least 436 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld⁴²At least$366,909 paid	at least 403 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld⁴²At least$336,332 paid	at least 394 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld⁴²At least$326,475 paid	at least 450 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld⁴²At least$380,171 paid	at least 455 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld⁴¹At least$411,023 paid	at least 391 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld⁴¹At least$354,868 paid	at least 362 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld⁴¹At least$329,229 paid	at least 354 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld⁴¹At least$305,745 paid	at least 442 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$391,663 paid	at least 504 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$438,681 paid	at least 486 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$423,979 paid	502 paid prescriptions in the quarter (2023Q4)⁴⁰Count$431,763 paid	at least 453 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$293,713 paid	at least 406 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$255,083 paid	at least 269 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$164,913 paid	at least 187 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$114,997 paid	at least 135 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$71,839 paid	at least 62 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$37,152 paid	34 paid prescriptions in the quarter (2025Q3)³⁸Count$21,029 paid	at least 11 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$5,439 paid	at least 11 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$8,628 paid
liraglutideliraglutide (generic)range 62 to 125	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	62 paid prescriptions in the quarter (2024Q3)⁴⁵Count$36,841 paid	76 paid prescriptions in the quarter (2024Q4)⁴⁵Count$43,628 paid	125 paid prescriptions in the quarter (2025Q1)⁴⁴Count$53,792 paid	at least 158 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$50,493 paid	at least 212 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$63,071 paid	at least 149 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$40,018 paid	at least 73 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$17,357 paid

What this page cannot tell you

Whether Florida Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Florida in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, FL
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "97"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, FL
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, FL
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, FL
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like ZEPBOUND%, state FL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, FL
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like ZEPBOUND%, state FL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, FL
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like ZEPBOUND%, state FL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, FL
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "2148"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, FL
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "1260"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, FL
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "915"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, FL
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "764"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, FL
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "171"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, FL
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like MOUNJARO%, state FL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, FL
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "144"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, FL
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "96"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, FL
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, FL
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, FL
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, FL
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, FL
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "5867"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, FL
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "10597"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, FL
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "10627"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, FL
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "6165"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, FL
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1237"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, FL
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1077"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, FL
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "75"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, FL
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "120"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, FL
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "227"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, FL
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "313"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, FL
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "188"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, FL
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "170"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, FL
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, FL
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, FL
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, FL
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "43"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, FL
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "25"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, FL
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "31"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, FL
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, FL
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "102"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, FL
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "235"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, FL
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "280"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, FL
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "302"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, FL
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "291"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, FL
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state FL, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "FL", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "21"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, FL
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state FL, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "63"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, FL
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state FL, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "41"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, FL
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state FL, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like LIRAGLUTID%, state FL, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, FL
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state FL, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like LIRAGLUTID%, state FL, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, FL
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state FL, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "FL", "product_name": "product_name like LIRAGLUTID%, state FL, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 41 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 7 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Florida Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.